CDKL5 and craniodiaphyseal dysplasia: From a molecular point of view in fact, male CDD patients do not have a functional Cdkl5 protein, while females, in whom the pathogenic variant always occurs in heterozygosity, have about 50 % of cells expressing the wild type protein and the remaining cells expressing the mutated allele, due to random X inactivation during development [22].